Cargando…
The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis
BACKGROUND: Despite the increasing prevalence of type 2 diabetes mellitus (T2DM), limited pharmacologic options are available for prevention. Cholesteryl ester transfer protein inhibitors (CETPis) have been studied primarily as a therapy to reduce cardiovascular disease, but have also been shown to...
Autores principales: | Dangas, Katerina, Navar, Ann-Marie, Kastelein, John J P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729761/ https://www.ncbi.nlm.nih.gov/pubmed/35441656 http://dx.doi.org/10.1093/ehjcvp/pvac025 |
Ejemplares similares
-
CETP and SGLT2 inhibitor combination therapy improves glycemic control
por: Khomtchouk, Bohdan B., et al.
Publicado: (2023) -
Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014) -
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017) -
CETP inhibitor evacetrapib enters mouse brain tissue
por: Phénix, Jasmine, et al.
Publicado: (2023) -
CETP inhibitors and cardiovascular disease: Time to think again
por: Miller, Norman E
Publicado: (2014)